Study of the Spermatic Characteristics of Patients With Fabry Disease
NCT04073888 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22
Last updated 2019-08-29
Summary
The objective of this project is to estimate the prevalence of spermatic abnormalities in patients with Fabry disease.The main objective of this project is to estimate the prevalence of spermatic abnormalities in patients with Fabry disease.
Conditions
Interventions
- PROCEDURE
-
Semen collection
Semen collection for seminogram and spermocytogram
Sponsors & Collaborators
-
University Hospital, Bordeaux
lead OTHER
Principal Investigators
-
Alice PAPAXANTHOS, Dr · University Hospital, Bordeaux
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-02-20
- Primary Completion
- 2013-10-18
- Completion
- 2013-10-18
More Related Trials
-
T1 Mapping in Fabry Disease
NCT05923788 ·Status: RECRUITING ·Phase: NA
-
Detection of Fabry Disease in Chronic Renal Failure Patients in Area Provence - Alpes - Côte d'Azur
NCT01374997 ·Status: COMPLETED ·Phase: NA
-
A Study of Fabrazyme in Pediatric Patients With Fabry Disease
NCT00074958 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry Disease
NCT02489344 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Prevalence of Fabry Disease in French Dialysis Patients
NCT02843334 ·Status: UNKNOWN
-
Inflammatory Pathways and Cardiac Growth Factors Associated With Fabry Disease Cardiomyopathy
NCT04724083 ·Status: UNKNOWN
-
A Long Term Follow-Up Study of Fabry Disease Subjects Treated With FLT190
NCT04455230 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Fabry and Cardiomyopathy (FaCard)
NCT01429597 ·Status: WITHDRAWN
-
Prevalence and Characteristics of Fabry Disease (FD) in Patients With Stroke or Small Fiber Neuropathy
NCT03230149 ·Status: COMPLETED
-
Autologous Stem Cell Transplantation of Cells Engineered to Express Alpha-Galactosidase A in Patients With Fabry Disease
NCT02800070 ·Status: COMPLETED ·Phase: PHASE1
-
Biomarkers and Cardiac Imaging Diagnostic Assay for Monitoring Patients With Fabry Disease
NCT05698901 ·Status: RECRUITING
-
A One Visit Follow Up of Adults With Fabry Disease Who Started Long-term Enzyme Replacement Therapy As Children
NCT04002531 ·Status: COMPLETED ·Phase: NA
-
Assess Urine Biomarkers to Predict Nephropathy in Fabry Disease
NCT06065605 ·Status: UNKNOWN
-
A Study of Agalsidase Alfa Enyzme Replacement Therapy in Chinese Children and Adults With Fabry Disease
NCT07187440 ·Status: RECRUITING
-
Fabry's Disease and Pregnancy (PREFAB)
NCT02582294 ·Status: TERMINATED
-
Study of the Safety and Biologic Activity of AL01211 in Treatment Naive Males With Classic Fabry Disease
NCT06114329 ·Status: RECRUITING ·Phase: PHASE2
-
Screening for Fabry Disease in a Pediatric Population at Risk
NCT02152189 ·Status: COMPLETED
-
A Study of Renal Function in Treatment-naïve, Young Male Patients With Fabry Disease
NCT01839526 ·Status: TERMINATED ·Phase: PHASE1
-
Understanding Fabry Disease Therapy Choices Through the Eyes of the Patients
NCT04804566 ·Status: COMPLETED
-
Cardiovasculorenal Phenotyping in Fabry Disease Through Noninvasive Testing
NCT05699265 ·Status: TERMINATED
-
A Fabry Disease Gene Therapy Study
NCT04040049 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
MigALastat Therapy Adherence Among FABRY Patients: A Prospective Multicentral Observational Study
NCT03683966 ·Status: UNKNOWN
-
Prevalence of Fabry's Disease in a Population of Patients With Chronic Pains
NCT01178164 ·Status: COMPLETED ·Phase: NA
-
Assessment Of Liver and Spleen Fibrosis in Patients With Gaucher Disease Using Fibroscan
NCT01898325 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Efficacy and Safety of Agalsidase Beta in Heterozygous Females for Fabry Disease
NCT00487630 ·Status: UNKNOWN ·Phase: PHASE4